Vertaling van "toxicology of environmental " (Frans → Nederlands) :

Toutefois, le document Toxicological Profile for Chromium, publié par le Département américain de la Santé et des Services humains (septembre 2000, p. 329), se réfère à la littérature de l'OMS (European Standard for Drinking Water, 2e édition, 1970, Genève, p. 33, et Environmental Health Criteria: Chromium 6, 1988, Genève, p. 197) en ce qui concerne le plafond de 0,05 μg/l autorisé en Europe pour la présence de chrome hexavalent dans l'eau potable.
In het document “Toxicological Profile for Chromium” (USDH en HS, september 2000, blz. 329) wordt 0,05µg/lt zeswaardig chroom in drinkwater als Europese grenswaarde aangegeven, en wordt verwezen naar literatuur van de Wereldgezondheidsorganisatie (1970, tweede editie, Genève 33, “European Standard for Drinking Water” en 1988, ed. Genève 197, “Environmental Health Criteria: Chromium 6”).

Toutefois, le document Toxicological Profile for Chromium, publié par le Département américain de la Santé et des Services humains (septembre 2000, p. 329), se réfère à la littérature de l'OMS (European Standard for Drinking Water, 2édition, 1970, Genève, p. 33, et Environmental Health Criteria: Chromium 6, 1988, Genève, p. 197) en ce qui concerne le plafond de 0,05 μg/l autorisé en Europe pour la présence de chrome hexavalent dans l'eau potable.
In het document "Toxicological Profile for Chromium" (USDH en HS, september 2000, blz. 329) wordt 0,05µg/lt zeswaardig chroom in drinkwater als Europese grenswaarde aangegeven, en wordt verwezen naar literatuur van de Wereldgezondheidsorganisatie (1970, tweede editie, Genève 33, "European Standard for Drinking Water" en 1988, ed. Genève 197, "Environmental Health Criteria: Chromium 6").

(1) Adler, I. D (1986), Clastogenic Potential in Mouse Spermatogonia of Chemical Mutagens Related to their Cell-Cycle Specifications, in : Genetic Toxicology of Environmental Chemicals, Part B : Genetic Effects and Applied Mutagenesis, Ramel, C. , Lambert B., and Magnusson, J (eds).
(1) Adler, I. D., (1986). Clastogenic Potential in Mouse Spermatogonia of Chemical Mutagens Related to their Cell-Cycle Specifications.

(5) Fielder, R. J., Alleen, J. A., Boobis, A. R., Botham, P. A., Doe, J., Esdaile, D. J., Gatehouse, D. G., Hodson- Walker, G., Morton, D. B., Kirkland, D. J. and Richold, M (1992), Report of British Toxicology Society/ UK, Environmental Mutagen Society Working Group : Dose setting in In Vivo Mutagenicity Assays, Mutagenesis, 7, pp. 313-319.
(5) Fielder, R.J., Allen, J.A., Boobis, A.R., Botham, P.A., Doe, J., Esdaile, D.J., Gatehouse, D.G., Hodson-Walker, G., Morton, D.B., Kirkland, D.J. and Richold, M (1992). Report of British Toxicology Society/UK Environmental Mutagen Society Working Group : Dose setting in In Vivo Mutagenicity Assays.

(7) Fielder, R. J., Allen, J. A., Boobis, A. R., Botham, P. A., Doe, J., Esdaile, D. J., Gatehouse, D. G., Hodson- Walker, G., Morton, D. B., Kirkland D. J. and Richold, M (1992), Report of British Toxicology Society/UK Environmental Mutagen Society Working group : Dose setting in In Vivo Mutagenicity Assays, Mutagenesis, 7, pp. 313-319.
(7) Fielder, R.J., Allen, J.A., Boobis, A.R., Botham, P.A., Doe, J., Esdaile, D.J., Gatehouse, D.G., Hodson-Walker, G., Morton, D.B., Kirkland, D.J. and Richold, M (1992). Report of British Toxicology Society/UK Environmental Mutagen Society Working Group : Dose setting in In Vivo Mutagenicity Assays, Mutagenesis, 7, pp. 313-319.

(13) Fielder, R. J., Allen, J. A., Boobis, A. R., Botham, P. A., Doe, J., Esdaile, D. J., Gatehouse, D. G., HodsonWalker, G., Morton, D. B., Kirkland, D. J. and Rochold, M (1992), Report of British Toxicology Society/UK Environmental Mutagen Society Working Group : Dose Setting in In Vivo Mutagenicity Assays, Mutagenesis, 7, pp. 313-319.
(13) Fielder, R.J., Allen, J.A., Boobis, A.R., Botham, P.A., Doe, J., Esdaile, D.J., Gatehouse, D.G., Hodson-Walker, G., Morton, D.B., Kirkland, D.J. and Rochold, M (1992). Report of British Toxicology Society/UK Environmental Mutagen Society Working Group : Dose Setting in In vivo Mutagenicity Assays.